| PharmaSUG |
2015 |
Considerations in Submitting Non-Standard Variables: Supplemental Qualifiers, Findings About, or a Custom Findings Domain |
Jerry Salyers, Fred Wood |
source |
6 |
| PHUSE EU |
2014 |
Considerations in Creating Transparent SDTM-Based Datasets |
Jerry Salyers |
source presentation source |
8 |
| PharmaSUG |
2014 |
Considerations in Creating SDTM Trial Design Datasets |
Jerry Salyers, Kimberly Minkalis, Fred Wood |
source |
9 |
| PharmaSUG |
2014 |
Considerations in the Submission of Exposure Data in SDTM-Based Datasets |
Fred Wood, Jerry Salyers, Kristin Kelly |
source |
6 |
| PharmaSUG |
2013 |
Considerations in the Use of Timing Variables in Submitting SDTM-Compliant Datasets |
Jerry Salyers, Fred Wood |
source |
6 |
| PharmaSUG |
2012 |
Considerations in the Submission of Exposure Data in an SDTM-Compliant Format |
Fred Wood, Jerry Salyers |
source |
4 |
| PharmaSUG |
2012 |
Considerations in the Submission of Pharmacokinetics (PK) Data in an SDTM-Compliant Format |
Fred Wood, Peter Schaefer |
source |
8 |